Sino Biopharmaceuticals announced that Sirolimus Tablets (trademark name: Qingweishi) developed by it have received marketing approval from the National Medical Products Administration, which is the first product, since China implemented the early resolution mechanism for drug patent disputes (drug

1. PatentIn 2023, the number of authorized invention patents in China was 921,000, the number of authorized utility model patents was 2.09 million, and the number of authorized industrial design patents was 499,100. Among them, there were 4.015 million valid domestic invention patents (excluding Hon

On December 12, 2023, the Brazilian Patent and Trademark Office (BPTO) published Opinion No. 1 19/2023, significantly impacting patent applications.Opinion No. 19/2023 establishes that patent applicants are prohibited from introducing amendments during an administrative appeal against the rejection

As recently reported, the BRPTO announced a series of new guidelines regarding the processing of patent, trademark and industrial design applications. Check out our latest newsletters about changes to trademarks and patents here.Specifically in relation to industrial designs, the BRPTO gave normativ

In the field of solid-state batteries in the green and low-carbon industry, as of May this year, the number of global solid-state battery key technology patent applications was 20,798, of which 7,640 were from China, accounting for 36.7%; in the past 5 years, the average annual growth rate of Chinas